Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Colorectal Neoplasms 34Colonic Neoplasms 18Rectal Neoplasms 14Pancreatic Neoplasms 8Esophageal Neoplasms 7Adenomatous Polyposis Coli 7Liver Neoplasms 5Carcinoma, Hepatocellular 4Neoplasm Metastasis 3Turcot syndrome 2Thymoma 2Neoplasms 2Lung Neoplasms 2Locally Advanced Rectal Cancer 2Hand-Foot Syndrome 2Gastrointestinal Neoplasms 2Esophageal Squamous Cell Carcinoma 2Breast Neoplasms 2Adenocarcinoma Of Esophagus 2Thrombocytosis 1Stomach Neoplasms 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Polyps 1Pancreatic Cancer Metastatic 1Pain, Postoperative 1

Interventions

Celecoxib 2Capecitabine 2tegafur-gimeracil-oteracil 1S 1 (combination) 1Radiotherapy 1Pyridoxine 1Pharmacokinetics 1Blood Specimen Collection 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hand-Foot Syndrome × Celecoxib × Gastrointestinal × Clear all
NCT05327751 2022-04-14

HFS

Tanta University

Phase 3 Unknown
44 enrolled
Gastrointestinal

Colorectal Neoplasms, Hand-Foot Syndrome

NCT00305643 2015-12-24

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

M.D. Anderson Cancer Center

Phase 3 Terminated
11 enrolled 7 charts
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Pain, Rectal Neoplasms, Colorectal Neoplasms, Breast Neoplasms, Male, Hand-Foot Syndrome, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡